Research Studies
Hydroxynorketamine DOD – (2R,6R)-Hydroxynorketamine a Novel Therapeutic Analgesic for the Treatment of Neuropathic Pain.
Sponsored by: National Library of Medicine.
Transition from Acute to Chronic Pain in Total Knee Arthroplasty Patients: Identifying Resilience and Vulnerability Profiles.
Sponsored by: National Institutes of Health (NIH).
NIH sponsored research studies:
John Burns, PhD and Asokumar Buvanendran, MD.
Title: Transition from Acute to Chronic Pain in Total Knee Arthroplasty Patients: Identifying Resilience and Vulnerability Profiles.
Sponsored by: National Institutes of Health (NIH).
Department of Defense (DOD) sponsored research studies:
DOD PTSD – Preventing the Development of Chronic Pain: Treating PTSD at Acute Pain Onset
Investigator sponsored research studies:
A2CPS – Acute to Chronic Pain Signatures Program
XANADO - External sensing and Neuromodulation to Assess Diabetic Pain outcomes
INSPiRE - Inhaled Sedation vs Propofol in Respiratory Failure - ICU (INSPiRE-ICU) 2 Study
Looking for neuropathic pain treatment?
Join the Rush Ketamine metabolite research study as we learn about novel therapeutics to treat neuropathic pain
You may be eligible if you:
- Are aged 18 to 75 years
- Have had >3 months of pain in an extremity
- Have suspected neuropathic pain
Potential Benefits:
- You may have decreased pain
- You may have improved sleep, physical function and quality of life
Taking part in the HNK research study is up to you. If you join, you can leave at any time.
For more information, please contact:
Kathryn Schmitt
Study Coordinator
(312) 942-3421
kathryn_L_schmitt@rush.edu
Or Visit us at:
Clinicaltrials.gov
Identifier:
NCT05864053
